Literature DB >> 15868446

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles.

Evan Matros1, Zhigang C Wang, Gabriela Lodeiro, Alexander Miron, J Dirk Iglehart, Andrea L Richardson.   

Abstract

BRCA1 is a tumor suppressor gene that functions in DNA repair. Basal-like tumors are a distinctive subtype of breast cancer defined by gene expression profiles. Hereditary BRCA1 breast tumors and basal-like sporadic tumors have a similar phenotype and gene expression signature, suggesting involvement of BRCA1 in the pathogenesis of sporadic basal-like cancer. This study evaluates the role of BRCA1 in sporadic breast tumorigenesis. BRCA1 protein expression and promoter methylation are compared to tumor histopathology and gene expression profiles. We find BRCA1 protein expression correlates with tumor mitotic rate, consistent with normal cell-cycle regulation of the BRCA1 gene. Methylation is found in 21% of tumors and is associated with lower BRCA1 protein, but not with specific pathologic features. Basal-like tumors, defined by hierarchical clustering of gene expression, have infrequent BRCA1 methylation and high levels of BRCA1 protein expression consistent with their high mitotic rate. Tumors with BRCA1 promoter methylation are present in all expression clusters; however, a subgroup of ER-positive high-grade tumors has a significantly greater number of BRCA1 methylated tumors. Absence of BRCA1 promoter methylation and high levels of BRCA1 expression in basal-like sporadic tumors suggest alternate explanations for the phenotypic similarities of these tumors to hereditary BRCA1 tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868446     DOI: 10.1007/s10549-004-7603-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  65 in total

1.  Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.

Authors:  Da Pang; Yashuang Zhao; Weinan Xue; Ming Shan; Yanbo Chen; Youxue Zhang; Guoqiang Zhang; Feng Liu; Dalin Li; Yanmei Yang
Journal:  Med Oncol       Date:  2011-11-11       Impact factor: 3.064

2.  Basal-like breast cancer displays distinct patterns of promoter methylation.

Authors:  Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar
Journal:  Cancer Biol Ther       Date:  2010-06-18       Impact factor: 4.742

Review 3.  Triple-negative breast cancer: disease entity or title of convenience?

Authors:  Lisa Carey; Eric Winer; Giuseppe Viale; David Cameron; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2010-09-28       Impact factor: 66.675

Review 4.  Biological Subtypes of Triple-Negative Breast Cancer.

Authors:  Michael Hubalek; Theresa Czech; Hannes Müller
Journal:  Breast Care (Basel)       Date:  2017-02-20       Impact factor: 2.860

5.  Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.

Authors:  K Y-K Chan; W Liu; J-R Long; S-P Yip; S-Y Chan; X-O Shu; D T-T Chua; A N-Y Cheung; J C-Y Ching; H Cai; G K-H Au; M Chan; W Foo; H Y-S Ngan; Y-T Gao; E S-W Ngan; M-M Garcia-Barceló; Wei Zheng; U-S Khoo
Journal:  J Med Genet       Date:  2008-09-09       Impact factor: 6.318

Review 6.  Stromal cells in tumor microenvironment and breast cancer.

Authors:  Yan Mao; Evan T Keller; David H Garfield; Kunwei Shen; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

7.  Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.

Authors:  Marise R Heerma van Voss; Petra van der Groep; Jos Bart; Elsken van der Wall; Paul J van Diest
Journal:  BMC Cancer       Date:  2010-04-16       Impact factor: 4.430

8.  PTK6 regulates IGF-1-induced anchorage-independent survival.

Authors:  Hanna Y Irie; Yashaswi Shrestha; Laura M Selfors; Fabianne Frye; Naoko Iida; Zhigang Wang; Lihua Zou; Jun Yao; Yiling Lu; Charles B Epstein; Sridaran Natesan; Andrea L Richardson; Kornelia Polyak; Gordon B Mills; William C Hahn; Joan S Brugge
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  A metabolic prosurvival role for PML in breast cancer.

Authors:  Arkaitz Carracedo; Dror Weiss; Amy K Leliaert; Manoj Bhasin; Vincent C J de Boer; Gaelle Laurent; Andrew C Adams; Maria Sundvall; Su Jung Song; Keisuke Ito; Lydia S Finley; Ainara Egia; Towia Libermann; Zachary Gerhart-Hines; Pere Puigserver; Marcia C Haigis; Elefteria Maratos-Flier; Andrea L Richardson; Zachary T Schafer; Pier P Pandolfi
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

10.  Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.

Authors:  Yang Li; Lihua Zou; Qiyuan Li; Benjamin Haibe-Kains; Ruiyang Tian; Yan Li; Christine Desmedt; Christos Sotiriou; Zoltan Szallasi; J Dirk Iglehart; Andrea L Richardson; Zhigang Charles Wang
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.